• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2020 Aug 28;26(12).
doi: 10.3201/eid2612.203334. Online ahead of print.
Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020

William T Hu, J Christina Howell, Tugba Ozturk, Karima Benameur, Leda C Bassit, Richard Ramonell, Kevin S Cashman, Shama Pirmohammed, John D Roback, Vincent C Marconi, Irene Yang, Valerie V Mac, Daniel Smith, Ignasio Sanz, Whitney Wharton, F Eun-Hyung Lee, Raymond F Schinazi

Abstract

Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be investigated separately from severe COVID-19.

Keywords: 2019 novel coronavirus disease; Atlanta; COVID-19; Georgia; SARS-CoV-2; USA; antibody profiles; coronavirus disease; immunoglobulin; infection severity; neutralization; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom